Antianginal and myocardial metabolic properties of verapamil in coronary artery disease
- 1 December 1980
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 46 (6), 1019-1026
- https://doi.org/10.1016/0002-9149(80)90361-6
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Reversal of the cardiovascular effects of verapamil by calcium and sodium: differences between electrophysiologic and hemodynamic responses.Circulation, 1979
- Effects of verapamil on myocardial performance in coronary disease.Circulation, 1979
- In vivo validation of a thermodilution method to determine regional left ventricular blood flow in patients with coronary disease.Circulation, 1978
- Coronary sinus reflux. A source of error in the measurement of thermodilution coronary sinus flow.Circulation, 1978
- Verapamil in the management of supraventricular tachyarrhythmias occurring after a recent myocardial infarction.Circulation, 1978
- Electrophysiologic and hemodynamic effects of verapamin. Correlation with plasma drug concentrations.Circulation, 1978
- Effects of Coronary Arteriography on Myocardial Blood FlowCirculation, 1972
- Effect of verapamil on contractility, oxygen utilization, and calcium exchangeability in mammalian heart muscleCardiovascular Research, 1972
- Measurement of Coronary Sinus Blood Flow by Continuous Thermodilution in ManCirculation, 1971
- Temporal Relationships of Myocardial Lactate Metabolism, Left Ventricular Function, and S-T Segment Depression During Angina Precipitated by ExerciseCirculation, 1969